Cooper Simon Peter 4
4 · Keros Therapeutics, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
Cooper Simon Peter
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-13+40,000→ 40,000 totalExercise: $56.18Exp: 2034-02-12→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on February 13, 2025, and 6.25% of the shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.